Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

Title
Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
Authors
Keywords
-
Journal
LUNG CANCER
Volume 78, Issue 1, Pages 76-80
Publisher
Elsevier BV
Online
2012-07-24
DOI
10.1016/j.lungcan.2012.06.011

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started